252 related articles for article (PubMed ID: 25030587)
21. Emodin potentiates the antitumor effects of gemcitabine in pancreatic cancer cells via inhibition of nuclear factor-κB.
Liu A; Chen H; Tong H; Ye S; Qiu M; Wang Z; Tan W; Liu J; Lin S
Mol Med Rep; 2011; 4(2):221-7. PubMed ID: 21468555
[TBL] [Abstract][Full Text] [Related]
22. Gemcitabine inhibits proliferation and induces apoptosis in human pancreatic cancer PANC-1 cells.
Yong-Xian G; Xiao-Huan L; Fan Z; Guo-Fang T
J Cancer Res Ther; 2016 Oct; 12(Supplement):1-4. PubMed ID: 27721241
[TBL] [Abstract][Full Text] [Related]
23. Inducing apoptosis and enhancing chemosensitivity to gemcitabine via RNA interference targeting Mcl-1 gene in pancreatic carcinoma cell.
Wei SH; Dong K; Lin F; Wang X; Li B; Shen JJ; Zhang Q; Wang R; Zhang HZ
Cancer Chemother Pharmacol; 2008 Nov; 62(6):1055-64. PubMed ID: 18297287
[TBL] [Abstract][Full Text] [Related]
24. Treatment with gemcitabine and TRA-8 anti-death receptor-5 mAb reduces pancreatic adenocarcinoma cell viability in vitro and growth in vivo.
DeRosier LC; Huang ZQ; Sellers JC; Buchsbaum DJ; Vickers SM
J Gastrointest Surg; 2006 Nov; 10(9):1291-300; discussion 1300. PubMed ID: 17114015
[TBL] [Abstract][Full Text] [Related]
25. Alteration of the intrinsic apoptosis pathway is involved in Notch-induced chemoresistance to gemcitabine in pancreatic cancer.
Du X; Zhao YP; Zhang TP; Zhou L; Chen G; Wang TX; You L; Shu H
Arch Med Res; 2014 Jan; 45(1):15-20. PubMed ID: 24316112
[TBL] [Abstract][Full Text] [Related]
26. Mesothelin confers pancreatic cancer cell resistance to TNF-α-induced apoptosis through Akt/PI3K/NF-κB activation and IL-6/Mcl-1 overexpression.
Bharadwaj U; Marin-Muller C; Li M; Chen C; Yao Q
Mol Cancer; 2011 Aug; 10():106. PubMed ID: 21880146
[TBL] [Abstract][Full Text] [Related]
27. Effects of ginsenoside Rh2 on growth and migration of pancreatic cancer cells.
Tang XP; Tang GD; Fang CY; Liang ZH; Zhang LY
World J Gastroenterol; 2013 Mar; 19(10):1582-92. PubMed ID: 23538603
[TBL] [Abstract][Full Text] [Related]
28. Synergistic effects of baicalein with gemcitabine or docetaxel on the proliferation, migration and apoptosis of pancreatic cancer cells.
Liu P; Feng J; Sun M; Yuan W; Xiao R; Xiong J; Huang X; Xiong M; Chen W; Yu X; Sun Q; Zhao X; Zhang Q; Shao L
Int J Oncol; 2017 Dec; 51(6):1878-1886. PubMed ID: 29039524
[TBL] [Abstract][Full Text] [Related]
29. Effects of a non thermal plasma treatment alone or in combination with gemcitabine in a MIA PaCa2-luc orthotopic pancreatic carcinoma model.
Brullé L; Vandamme M; Riès D; Martel E; Robert E; Lerondel S; Trichet V; Richard S; Pouvesle JM; Le Pape A
PLoS One; 2012; 7(12):e52653. PubMed ID: 23300736
[TBL] [Abstract][Full Text] [Related]
30. Secreted protein acidic and rich in cysteine inhibits the growth of human pancreatic cancer cells with G1 arrest induction.
Mao Z; Ma X; Fan X; Cui L; Zhu T; Qu J; Zhang J; Wang X
Tumour Biol; 2014 Oct; 35(10):10185-93. PubMed ID: 25027401
[TBL] [Abstract][Full Text] [Related]
31. [Enhancing effects of celecoxib on the growth inhibition of pancreatic carcinoma by gemcitabine treatment].
Xu G; Wu K; Wang XP; Zhao S
Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):986-91. PubMed ID: 16060994
[TBL] [Abstract][Full Text] [Related]
32. E2F-1 gene therapy induces apoptosis and increases chemosensitivity in human pancreatic carcinoma cells.
Elliott MJ; Farmer MR; Atienza C; Stilwell A; Dong YB; Yang HL; Wong SL; McMasters KM
Tumour Biol; 2002; 23(2):76-86. PubMed ID: 12065845
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of cyclin D1 promotes tumor cell growth and confers resistance to cisplatin-mediated apoptosis in an elastase-myc transgene-expressing pancreatic tumor cell line.
Biliran H; Wang Y; Banerjee S; Xu H; Heng H; Thakur A; Bollig A; Sarkar FH; Liao JD
Clin Cancer Res; 2005 Aug; 11(16):6075-86. PubMed ID: 16115953
[TBL] [Abstract][Full Text] [Related]
34. Enhancement of the effects of gemcitabine against pancreatic cancer by oridonin via the mitochondrial caspase-dependent signaling pathway.
Liu DL; Bu HQ; Jin HM; Zhao JF; Li Y; Huang H
Mol Med Rep; 2014 Dec; 10(6):3027-34. PubMed ID: 25242370
[TBL] [Abstract][Full Text] [Related]
35. Bcl-x(L) antisense oligonucleotides induce apoptosis and increase sensitivity of pancreatic cancer cells to gemcitabine.
Xu Z; Friess H; Solioz M; Aebi S; Korc M; Kleeff J; Büchler MW
Int J Cancer; 2001 Oct; 94(2):268-74. PubMed ID: 11668508
[TBL] [Abstract][Full Text] [Related]
36. BRM/SMARCA2 promotes the proliferation and chemoresistance of pancreatic cancer cells by targeting JAK2/STAT3 signaling.
Zhang Z; Wang F; Du C; Guo H; Ma L; Liu X; Kornmann M; Tian X; Yang Y
Cancer Lett; 2017 Aug; 402():213-224. PubMed ID: 28602977
[TBL] [Abstract][Full Text] [Related]
37. [Microwave Hyperthermia Combined with Gemcitabine Inhibits Proliferation
and Induces Apoptosis of Human Lung Squamous Carcinoma Cells].
Yang Y; Zhao Y; Ma S; Yang D
Zhongguo Fei Ai Za Zhi; 2018 Nov; 21(11):805-814. PubMed ID: 30454541
[TBL] [Abstract][Full Text] [Related]
38. In vitro Study of the Antagonistic Effect of Low-dose Liquiritigenin on Gemcitabine-induced Capillary Leak Syndrome in Pancreatic Adenocarcinoma via Inhibiting ROS- Mediated Signalling Pathways.
Wu W; Xia Q; Luo RJ; Lin ZQ; Xue P
Asian Pac J Cancer Prev; 2015; 16(10):4369-76. PubMed ID: 26028101
[TBL] [Abstract][Full Text] [Related]
39. In vitro and in vivo cytotoxicity of troglitazone in pancreatic cancer.
Fujita M; Hasegawa A; Yamamori M; Okamura N
J Exp Clin Cancer Res; 2017 Jul; 36(1):91. PubMed ID: 28673319
[TBL] [Abstract][Full Text] [Related]
40. Synergistic cytotoxicity and pharmacogenetics of gemcitabine and pemetrexed combination in pancreatic cancer cell lines.
Giovannetti E; Mey V; Danesi R; Mosca I; Del Tacca M
Clin Cancer Res; 2004 May; 10(9):2936-43. PubMed ID: 15131028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]